District Court, D. New Jersey August 22, 2017, Civil No. 15-2155 (RMB/JS), Civil No. 15-4524 (RMB/JS) (Reckitt Benckiser LLC v. Amneal Pharmaceuticals LLC)

Also known as

United States · · · 22-08-2017

OPINION

RENÉE MARIE BUMB, UNITED STATES DISTRICT JUDGE

Plaintiff Reckitt Benekiser LLC (“Reck-itt” or “Plaintiff’) brings this Hatch-Wax-man action for patent infringement against Defendants Amneal Pharmaceuticals LLC (“Amneal”) and Dr. Reddy’s Laboratories, Inc. (“DRL”) (collectively, “Defendants”) pursuant to 35 U.S.C. § 271(e)(2)(A) and §§ 271(a), (b), and (c).

I. Reckitt’s Guaifenesin Drug Mucinex® and the Patents-in-Suit

This case involves Reckitt’s 'Mucinex® product, an extended-release guaifenesin tablet used as an expectorant that thins and loosens mucus and relieves'- chest congestion. Reckitt initially alleged that Amneal’s generic 600 mg and 1200 mg guaifenesin sustained-release tablets (“Amneal’s ANDA .products”) will infringe U.S. Patent Nos. 6,372,252 (the “’252 Patent”), 6,955,821 (the “’821 Patent”), and 7,838,032 (the “’032 Patent”). Similarly, Reckitt initially alleged that DRL’s generic 600 mg and 1200 mg guaifenesin and pseudoephedrine hydrochloride sustained-release tablets (“DRL’s ANDA Products”) will infringe the ’252, ’821, and ’032 Patents. After the filing of the Complaints, Reckitt dismissed its claims under- the ’252 Patent as to both Defendants [Docket Nos. 64, 65] and its claims under the ’821 Patent against Defendant DRL [Docket No. 64].1

At the heart of the dispute is whether Defendants’ ANDA Products have two distinct formulations, an immediate release formulation (“IR formulation”) and a sustained release formulation (“SR formulation”). Reckitt contends that they do. Defendants counter that their ANDA products are single formulation matrix tablets and therefore do not infringe the Patents-in-Suit.

A. The ’821 Patent

The ’821 Patent is entitled “Sustained Release Formulations of Guaifenesin and Additional Drug Ingredients” and is. a continuation-in-part of the ’252 Patent. Stipulated Facts (“SF”) [Docket No. 157] ¶8-9. The named inventors are Robert D. Davis, Ralph W. Blume, and Donald Jeffery Key-ser. SF If 10.

Read the full text

This document is published by courtlistener.com.

Moonlit adds the citation network, article-level links and cross-references, which are available to search for free.